1.In vitro study on immunoreaction of dendritic cell vaccine in renal cell carcinoma
Changhui FAN ; Baoping QIAO ; Jianguo WEN ; Yuanming QI ; Qiao RUAN
Chinese Journal of Urology 2009;30(8):515-517
Objective To investigate the antitumor effect of specific cytotoxic T lymphocytes induced by renal cell carcinoma multiple antigen peptide dendritic cell (DC) vaccine in vitro. Methods Dendritic cells were induced by hGM-CSF,hIL-4 from blood.Peptide of renal cell carcinoma cell line (RCC786-0)was got by citrate-phosphate buffer elution.Peripheral blood mononuclear cell was cultured.Multiple antigen peptide DC cell vaccine was obtained by acid-eluted peptide pulsed DC.The tumor antigen specific CTL was generated from activated T cell by vaccine.Killing activity of the tumor antigen specific CTL was activated by vaccine. Results Antigen peptide DC cell vaccine could show a strong cytotoxic activity of CTLs(31.93±5.05%),which was much higher than control groups(5.88±2.26%,8.03±6.70%,9.70±2.09%,9.35±3.58%). Conclusion Renal cell carcinoma antigen peptide DC vaccine could show a high antitumor effect in vitro.
2.Clinical management of procedural pain in the neonate:policy statement of prevention and management of procedural pain in the neonate by American Academy of Pediatrics Committee on Fetus and New-born and Section on Anesthesiology and Pain Medicine
Juan FAN ; Maojun LI ; Qing WU ; Changhui CHEN
Chinese Pediatric Emergency Medicine 2017;24(1):28-33
Neonatal pain is a common phenomenon. For a long time neonatal pain had not been focus on properly and managed appropriately. American Academy of Pediatrics Committee on Fetus and Newborn and Section on Anesthesiology and Pain Medicine published policy statement to emphasize the necessity of neonatal pain assessment,and summarize the neonatal operability pain assessment method,drug and non-drug control measures,also update prevention and management of procedural pain in the neonate in 2016. Until today the guideline for neonatal pain management has not yet been released in China. As the reference for clinicians in domestic,the content of policy statement will be reorganized and introduced.
3.Clinical management of bronchiolitis——clinical practice guidelines by American Academy of Pediatrics
Juan FAN ; Maojun LI ; Qing WU ; Changhui CHEN
Chinese Journal of Applied Clinical Pediatrics 2015;30(10):730-732
Bronchiolitis is a common lower respiratory tract viral infection in infants.Incidence of bronchiolitis is greatly increasing in recent years,and seriously affecting the health of children.In order to better manage bronchiolitis,American Academy of Pediatrics (AAP) convened a new subcommittee to review and revise the 2006 bronchiolitis guideline.This evidence-based guideline amended to provide new evidence of diagnosis,treatment and prevention bronchiolitis for the clinician.
4.Clinical management of measles in children—2015 report of the Committee on Infectious Diseases of American
Juan FAN ; Maojun LI ; Qing WU ; Changhui CHEN
Chinese Journal of Applied Clinical Pediatrics 2015;30(22):1684-1686
Measles is an acute viral disease, almost all deaths cases of measles in children occur in developing countries each year.Despite the availability of a safe and effective vaccine, measles is still one of the main causes of death of children in global area.2015 report of Committee on Infectious Diseases of American provided evidence of clinical diagnosis, treatment and prevention of measles.
5.Expression of nerve growth factor receptors p75 in human bladder carcinoma and its influence by hypoxia
Changhui FAN ; Jianguo WEN ; Baoping QIAO ; Zhenhe SUO ; Zhiqiang ZHU ; Qingwei WANG
Chinese Journal of Urology 2009;30(4):258-261
Objective To explore the expression of the nerve growth factor receptors p75 (p75NGFR) in human bladder carcinoma samples, and the effects of hypoxia on the expression of p75NGFR in human bladder cancer ceils. Methods The expression of p75NGFR in 107 bladder cancer and lymph node specimens were immunohistochemically investigated. The expression of p75NGFR in bladder cancer cell line (T24) was assessed by immunocytochemistry, and reverse tran-scription-PCR in the Normoxic Condition (air, 5%CO2) and in hypoxia condition(10%O2, 5%CO2, 85%N2). Results p75NGFR expressed in 46 of 107(43.0%) tumor samples. There was no signifi-cant correlation between p75NGFR and the factors such as gender, age, extent of the tumors, and pathologic grading(P0.05), p75NGFR was expressed in examined cell line T24, and also expressed in 5 of 24 bladder tumors in metastasized lymph node specimens. Hypoxia markedly down-regulated the expression of p75NGFR of T24 cell line at third day. Conclusions It is suggested that p75NGFR is expressed less in lymph node metastasis. Hypoxia markedly inhibited expression of p75NGFR of T24 cell lines.
6. Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy
Wenxia LI ; Liwen LIU ; Jing WANG ; Lei ZUO ; Fan YANG ; Nan KANG ; Changhui LEI
Chinese Journal of Cardiology 2017;45(12):1033-1038
Objective:
To evaluate the predicting value of the 2014 European Society of Cardiology (ESC) guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy (HCM), and to explore the predictors of adverse cardiovascular events in Chinese HCM patients.
Methods:
The study population consisted of a consecutive 207 HCM patients admitted in our center from October 2014 to October 2016. All patients were followed up to March 2017. The 5-year SCD probability of each patient was estimated using HCM Risk-SCD model based on electrocardiogram, echocardiography and cardiac magnetic resonance (CMR) examination results. The primary, second, and composite endpoints were recorded. The primary endpoint included SCD and appropriate ICD therapy, identical to the HCM Risk-SCD endpoint. The second endpoint included acute myocardial infarction, hospitalization for heart failure, thrombus embolism and end-stage HCM. The composite endpoint was either the primary or the second endpoint. Patients were divided into the 3 categories according to 5-year SCD probability assessed by HCM Risk-SCD model: low risk group<4%,intermediate risk group ≥4% to<6%, and high risk group≥6%.
Results:
(1) Prevalence of endpoints: All 207 HCM patients completed the follow-up (350 (230, 547) days). During follow-up, 8 (3.86%) patients reached the primary endpoints (3 cases of SCD, 3 cases of survival after defibrillation, and 2 cases of appropriate ICD discharge); 21 (10.14%) patients reached the second endpoints (1 case of acute myocardial infarction, 16 cases of heart failure hospitalization, 2 cases of thromboembolism, and 2 cases of end-stage HCM). (2) Predicting value of HCM Risk-SCD model: Patients with primary endpoints had higher prevalence of syncope and intermediate-high risk of 5-year SCD, as compared to those without primary endpoints (both
7. Diagnosis and management of infectious diarrhea in children: 2017 Infectious Diseases Society of America Cli-nical Practice Guidelines for Diagnosis and Management of Infectious Diarrhea
Juan FAN ; Maojun LI ; Qing WU ; Changhui CHEN
Chinese Journal of Applied Clinical Pediatrics 2019;34(15):1121-1126
Diarrhea is one of the main disease types of illness and death in children in developing countries, and infectious diarrhea is especially harmful to children′s health.A panel of multidisciplinary experts in management of infectious diarrhea in children and adults was convened in 2012.Panel participants included representatives from the Society for Healthcare Epidemiology of America (SHEA), Center for Disease Control and Prevention(CDC), and the Infectious Disease Society of America(IDSA) Standards and Practice Guidelines Committee (SPGC). In 2017, the panel issued a guideline for the diagnosis and treatment of infectious diarrhea, which was validated and recommended for the management of infectious diarrhea.Now, the part of the content on children in the guide was described.
8.Evidence-based management of bronchiolitis: A brief introduction of Australasian bronchiolitis guideline
Juan FAN ; Lan LI ; Min LI ; Changhui CHEN
Chinese Pediatric Emergency Medicine 2021;28(7):583-586
Bronchiolitis is the most common lower respiratory tract disorder in infants less than 12 months of age.Wide variation in the management of bronchiolitis exists between Australia and New Zealand, with up to 48% of infants admitted into hospital receiving treatment which is proved by high quality(Cochrane-level) evidence to be no benefit.For this reason, the Australian Guidelines Development Committee has developed the first high-quality Australian guidelines for bronchiolitis.The guideline provide suggestions for the management of children with bronchiolitis in emergency departments and general pediatric wards, and provide evidence for clinical practice.
9.Management of pediatric acute gastroenteritis in the outpatient setting——Introduction of "Clinical Practice Guideline for the Treatment of Pediatric Acute Gastroenteritis in the Outpatient Setting" of Children's National Medical Center, Washington, District of Columbia
Juan FAN ; Maojun LI ; Qing WU ; Changhui CHEN
Chinese Journal of Applied Clinical Pediatrics 2017;32(19):1459-1462
Acute gastroenteritis is a common illness in childhood that usually can be treated in the outpatient setting.Despite suggestion that acute gastroenteritis children with mild to moderate dehydration receive oral rehydration therapy as the main treatment,but there are still many children were given unnecessary tests and intravenous fluids.Children's National Medical Center,Washington,District of Columbia published practice guideline to clarify the basic principles of the evaluation and management of illness.The guideline for pediatric acute gastroenteritis management has not yet been released in China.As the reference for clinicians in domestic,the content of this practice guideline will be reorganized and introduced.
10.Expression of Transcription Factor Oct4 in Bladder Cancer Cell Line T24 and Its Effects on the Biological Characteristics of the Cells
ZHU ZHIQIANG ; WEN JIANGUO ; ZHENG XIANGYU ; WANG DAOXIE ; WANG QINGWEI ; FAN CHANGHUI
Journal of Huazhong University of Science and Technology (Medical Sciences) 2009;29(1):73-76
The expression of octamer binding factor 4 (Oct4) gene in bladder cancer cell line T24 and its effects on the biological characteristics of the cells were investigated.RT-PCR and Western blot were employed to detect the expression of Oct4 in T24 cells.The changes of biological charac-teristics in T24 cells were analyzed before and after gene-silencing by Boyden chamber and MTT.The results showed that the expression of Oct4 gene was detectable in T24 cells by RT-PCR and Western blot.The expression of Oct4 gene and protein was down-regulated by siRNA,and average number of transwell cells in interference group,negative control group and blank control group was 101.40±4.56,104.20±10.03 and 111.00±11.90,respectively.There was significant difference in the proliferation ability of the cells from 48 h,72 h to 96 h after the interference by siRNA between in-terference group and negative group or blank control group (P<0.05).It was suggested that Oct4 gene was related with proliferation ability ofT24 cells,but not with invasive capability.